MTOR [45–52] is a target associated with breast cancer, bladder cancer, hysteromyoma, laryngeal cancer, kidney cancer, liver cancer, thyroid cancer, epidermoid squamous cell carcinoma, and colorectal cancer. This evidence concerns the gene MTOR and liver cancer.